Pharmaceutical glass packaging market seen topping $27 billion by 2030

By AI, Created 2:45 PM UTC, May 22, 2026, /AGP/ – The Business Research Company says the global pharmaceutical glass packaging market will grow to more than $27 billion by 2030, led by North America and the U.S. The report points to rising demand for injectable drugs, biologics and sterile packaging as the main drivers.

Why it matters: - Pharmaceutical glass packaging sits at the center of drug safety for injectables, biologics and other sensitive formulations. - The market is projected to top $27 billion by 2030, underscoring strong demand for sterile, chemically stable primary packaging. - The report says the category will account for about 14% of the broader packaging products market and nearly 0.3% of the larger paper, plastics, rubber, wood and textile industry.

What happened: - The Business Research Company released a 2026 analysis of the global pharmaceutical glass packaging market. - The report forecasts 11% CAGR through 2030. - North America is expected to be the largest regional market in 2030 at $9 billion, up from $6 billion in 2025. - The USA is projected to be the largest country in 2030 at $8 billion, up from $5 billion in 2025. - The report says vials will be the biggest product segment in 2030, with 38% of the market, or about $10 billion. - The source text includes a free sample request and a full market report.

The details: - The market is segmented by product into ampoules, bottles, vials, syringes, cartridges and other product types. - The market is segmented by drug type into generic, branded and biologic. - The market is segmented by material into Type I, Type II and Type III. - The market is segmented by application into oral, injectable and other applications. - Vials are supported by demand for sterile packaging for injectable formulations. - Ready-to-fill and ready-to-sterilize formats are gaining adoption among pharmaceutical manufacturers. - The report says vials are also benefiting from demand for high-integrity containers for sensitive drug compositions. - Multi-dose and single-dose formats are expanding across therapeutic areas. - Glass-forming improvements are helping boost dimensional accuracy and performance reliability.

Between the lines: - The strongest growth drivers are tied to biologics, vaccines and specialty injectables, not traditional oral drugs. - Glass remains favored because it offers chemical resistance, barrier protection and compatibility with sensitive formulations. - Regulatory pressure is reinforcing the shift toward high-quality glass, especially where particulate contamination, extractables and leachables matter. - The report also points to rising investment in manufacturing capacity and packaging quality control as a response to tighter standards.

What’s next: - The report expects injectable drugs and biologics to add about 2.2% annual growth to the market. - Superior chemical resistance and product stability are projected to contribute about 2.0% annual growth. - Stringent drug-safety rules are projected to contribute about 1.8% annual growth. - Over the next five years, the ampoules market is projected to grow by $2 billion, bottles by $3 billion, vials by $4 billion, syringes by $1 billion, cartridges by $0.4 billion and other product types by $0.4 billion. - Collectively, those segments are expected to add more than $11 billion in market value by 2030.

The bottom line: - Pharmaceutical glass packaging is poised for steady, regulation-driven growth as injectable drugs and biologics continue to expand.